Interleukin-2 production in early rheumatoid arthritis. 1993

H G Taylor, and N B Nixon, and P T Dawes

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

H G Taylor, and N B Nixon, and P T Dawes
April 1987, The Journal of rheumatology,
H G Taylor, and N B Nixon, and P T Dawes
October 1987, The Journal of rheumatology,
H G Taylor, and N B Nixon, and P T Dawes
April 1989, The Journal of clinical investigation,
H G Taylor, and N B Nixon, and P T Dawes
February 1986, The Journal of rheumatology,
H G Taylor, and N B Nixon, and P T Dawes
January 1998, Clinical rheumatology,
H G Taylor, and N B Nixon, and P T Dawes
November 1988, European journal of immunology,
H G Taylor, and N B Nixon, and P T Dawes
December 2001, The Journal of rheumatology,
H G Taylor, and N B Nixon, and P T Dawes
January 2015, Scandinavian journal of rheumatology,
Copied contents to your clipboard!